Homeostasis model assessment in a population with mixed ethnicity: the 1992 Singapore National Health Survey. (Q51554081)

7 April 2018

title

Homeostasis model assessment in a population with mixed ethnicity: the 1992 Singapore National Health Survey. (English)

1 reference

7 April 2018

0 references

1

1 reference

7 April 2018

author name string

Lim SC

2

1 reference

7 April 2018

Chew SK

3

1 reference

7 April 2018

Tan BY

4

1 reference

7 April 2018

Tan CE

5

1 reference

7 April 2018

publication date

1 August 2000

1 reference

7 April 2018

Diabetes Research and Clinical Practice

published in

1 reference

7 April 2018

volume

49

1 reference

7 April 2018

issue

2-3

1 reference

7 April 2018

page(s)

159-168

1 reference

7 April 2018

Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

The homeostasis model in the San Antonio Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

A prospective analysis of the HOMA model. The Mexico City Diabetes Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

The natural history of impaired glucose tolerance in the Pima Indians.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

Are risk factors for conversion to NIDDM similar in high and low risk populations?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

Beta-cell dysfunction in first-degree relatives of patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Münster Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

Plasma triglyceride and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the World Health Organization. The DAIS Project Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

Troglitazone decreases the proportion of small, dense LDL and increases the resistance of LDL to oxidation in obese subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900152-2

7 January 2021

10.1016/S0168-8227(00)00152-2

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

10963828

1 reference

7 April 2018